"put IDCC at a strategic disadvantage" - my comments on whether or not the mysterious recent patent purchase is a worthwhile area of research:
(1) There is nothing we can access or learn that focused, industry expert, much more resourceful competitors can't also learn or don't already know. If anything, we are following them, not vice versa.
(2) The more we can know about IDCC's business the better. Ignorance is not bliss when it comes to investing.
(3) An $8M purchase(?) on patents (our business model) is important and apparently material enough to warrant itemized disclosure.
(4) If management is blowing off a serious question from shareholders with BS about "competitive reasons", then that says something about management, which concerns me. I really don't understand how there could be anything competitive about the source of these patents, unless another purchase is imminent, which could not be the case if the source is now a BK company with no more assets.
(5) If we incurred another $8M expense from a another failed litigation effort, which may be the situation, then that also says something relevant about management, especially if they give us BS to obscure the facts.
(6) Shareholders are probably the only interested folks that do not know the full story behind these obviously important patents.
I will go back to the case file and read a bit to see what the "breach of contract" with Lomp was about or even if it involved patents, which it may not.
MO,
Corp_Buyer